OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: Christopher Rowe

1 Projects | 1 Researchers | $718,286 Invested

2023

Florey Institute of Neuroscience and Mental Health

Christopher Rowe, BMBS, FRACP, MD, FAANMS

Diagnostics Accelerator Speech & Language Consortium: Harmonized Repository for the Exploration of Speech and Language Biomarkers for Neurodegenerative Disease

  • Funding Amount: $718,286
  • Organization Type: Academic/Nonprofit
  • Program: Diagnostics Accelerator
  • Target: Digital
  • Status: Active